BRPI0408136A - derivados heterocìclicos contendo nitrogênio tendo estirila 2,6-dissubstituìda - Google Patents

derivados heterocìclicos contendo nitrogênio tendo estirila 2,6-dissubstituìda

Info

Publication number
BRPI0408136A
BRPI0408136A BRPI0408136-6A BRPI0408136A BRPI0408136A BR PI0408136 A BRPI0408136 A BR PI0408136A BR PI0408136 A BRPI0408136 A BR PI0408136A BR PI0408136 A BRPI0408136 A BR PI0408136A
Authority
BR
Brazil
Prior art keywords
nitrogen
containing heterocyclic
disubstituted
heterocyclic derivatives
styryl
Prior art date
Application number
BRPI0408136-6A
Other languages
English (en)
Inventor
Kazumi Kikuchi
Makoto Oku
Jiro Fujiyasu
Norio Asai
Toshihiro Watanabe
Yukinori Nagakura
Hiroshi Tomiyama
Motoharu Sonegawa
Kazuo Tokuzaki
Yoshinori Iwai
Original Assignee
Astellas Pharma Inc
Kotobuki Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astellas Pharma Inc, Kotobuki Pharmaceutical Co Ltd filed Critical Astellas Pharma Inc
Publication of BRPI0408136A publication Critical patent/BRPI0408136A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/12—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with only hydrogen atoms attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4465—Non condensed piperidines, e.g. piperocaine only substituted in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/38—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings

Abstract

"DERIVADOS HETEROCìCLICOS CONTENDO NITROGêNIO TENDO ESTIRILA 2,6-DISSUBSTITUìDA". A presente invenção refere-se a um novo derivado heterocíclico contendo nitrogênio tendo estirila 2,6-dissubstituída e um sal farmaceuticamente aceitável do mesmo, e uma composição farmacêutica compreendendo o derivado heterocíclico contendo nitrogênio e um sal farmaceuticamente aceitável do mesmo, em particular, uma composição farmacêutica eficaz como um inibidor do canal de sódio, tendo uma excelente ação analgésica, especialmente sobre a dor neuropática, com efeitos colaterais minimizados.
BRPI0408136-6A 2003-03-07 2004-03-05 derivados heterocìclicos contendo nitrogênio tendo estirila 2,6-dissubstituìda BRPI0408136A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003061758 2003-03-07
PCT/JP2004/002842 WO2004078715A1 (ja) 2003-03-07 2004-03-05 ２，６－ジ置換スチリルを有する含窒素へテロ環誘導体

Publications (1)

Publication Number Publication Date
BRPI0408136A true BRPI0408136A (pt) 2006-03-01

Family

ID=32958970

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0408136-6A BRPI0408136A (pt) 2003-03-07 2004-03-05 derivados heterocìclicos contendo nitrogênio tendo estirila 2,6-dissubstituìda

Country Status (13)

Country Link
US (1) US8044206B2 (pt)
EP (1) EP1602645A4 (pt)
JP (1) JP4610480B2 (pt)
KR (1) KR20050114641A (pt)
CN (1) CN100516040C (pt)
AU (1) AU2004218115A1 (pt)
BR (1) BRPI0408136A (pt)
CA (1) CA2517081A1 (pt)
MX (1) MXPA05009290A (pt)
NO (1) NO20054607L (pt)
RU (1) RU2333200C2 (pt)
WO (1) WO2004078715A1 (pt)
ZA (1) ZA200507486B (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20050114641A (ko) * 2003-03-07 2005-12-06 아스텔라스세이야쿠 가부시키가이샤 2,6-이치환된 스티릴을 갖는 질소 함유 헤테로환 유도체
BRPI0415179A (pt) * 2003-10-07 2006-11-28 Renovis Inc derivados de amida como ligandos de canal de ìon e composições farmacêuticas e métodos de empregar as mesmas
KR20070050961A (ko) * 2004-09-01 2007-05-16 아스텔라스세이야쿠 가부시키가이샤 피페리딘 유도체 또는 이의 제약학적으로 허용되는 염
US7576099B2 (en) 2005-02-28 2009-08-18 Renovis, Inc. Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
US20080300243A1 (en) * 2005-02-28 2008-12-04 Kelly Michael G Amide Derivatives as Ion-Channel Ligands and Pharmaceutical Compositions and Methods of Using the Same
AU2006264649A1 (en) * 2005-06-30 2007-01-11 Prosidion Limited GPCR agonists
GB201106817D0 (en) 2011-04-21 2011-06-01 Astex Therapeutics Ltd New compound
TW201311679A (zh) 2011-08-04 2013-03-16 Takeda Pharmaceutical 含氮雜環化合物
GB201218850D0 (en) 2012-10-19 2012-12-05 Astex Therapeutics Ltd Bicyclic heterocycle compounds and their uses in therapy
US9980973B2 (en) 2012-10-19 2018-05-29 Astex Therapeutics Limited Bicyclic heterocycle compounds and their uses in therapy
GB201218862D0 (en) 2012-10-19 2012-12-05 Astex Therapeutics Ltd Bicyclic heterocycle compounds and their uses in therapy
GB201218864D0 (en) 2012-10-19 2012-12-05 Astex Therapeutics Ltd Bicyclic heterocycle compounds and their uses in therapy
MY186311A (en) 2013-12-20 2021-07-08 Astex Therapeutics Ltd Bicyclic heterocycle compounds and their uses in therapy
RU2676328C2 (ru) * 2014-02-14 2018-12-28 Тоа Эйо Лтд. Циклическое углеводородное соединение
WO2016160362A1 (en) 2015-03-31 2016-10-06 Allergan, Inc. Cyclosporins modified on the mebmt sidechain by heterocyclic rings
CN108503579B (zh) * 2018-03-28 2021-03-26 南京医科大学 芬太尼类似物及其应用
CN114948953A (zh) * 2021-06-29 2022-08-30 四川大学华西医院 一种杂原子取代芳香类化合物及其盐的用途

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3658797A (en) 1968-08-06 1972-04-25 Lilly Co Eli Novel 5-nitroimidazole antiparasitic agents
GB2069481B (en) 1980-02-13 1983-07-27 Farmos Oy Substituted imidazole derivatives
GB2092569B (en) 1981-02-05 1984-09-19 Farmos Oy Substituted imidazole derivatives and their preparation and use
GB2101114B (en) 1981-07-10 1985-05-22 Farmos Group Ltd Substituted imidazole derivatives and their preparation and use
FR2522325B1 (fr) 1982-02-26 1985-08-09 Delalande Sa Nouveaux derives aryliques de la piperazine, de l'homopiperazine et de n,n'-dialkyl diamino-1,2 ethane, leur procede de preparation et leur application en therapeutique
JPS60193966A (ja) 1984-03-13 1985-10-02 Ss Pharmaceut Co Ltd Ν−ニコチノイルピペラジン誘導体及びその製造法
JPH0631230B2 (ja) 1987-02-20 1994-04-27 山之内製薬株式会社 飽和ヘテロ環カルボン酸アミド誘導体
CN1030415A (zh) 1987-02-20 1989-01-18 山之内制药株式会社 饱和的杂环碳酰胺衍生物和它的制备方法
JPH01316359A (ja) 1988-03-23 1989-12-21 Idemitsu Kosan Co Ltd ピリジン誘導体および該誘導体を有効成分とする殺虫・殺ダニ剤
ES2096651T3 (es) 1990-06-07 1997-03-16 Merrell Pharma Inc Derivados de 1-piperidinil alcanoilarilsulfonamida.
JPH04342579A (ja) 1991-05-20 1992-11-30 Hiroyoshi Hidaka １−アリールスルホニルピペラジン類及び薬剤として許容され得るその酸付加塩
JP3134552B2 (ja) 1991-12-13 2001-02-13 宇部興産株式会社 シンナミルピペラジン誘導体、その製法及び農園芸用殺菌剤
EP0551617A3 (en) 1991-12-13 1993-11-03 Ube Industries Cinnamyl piperazine derivatives method of manufacturing the same and agricultural/horticultural fungicides containing cinnamyl piperazine derivatives
US5240943A (en) 1991-12-19 1993-08-31 G. D. Searle & Co. Benzopyran class iii antiarrhythmic agents
GB9226111D0 (en) 1992-12-15 1993-02-10 Smithkline Beecham Plc Madicaments
WO1995024390A1 (en) 1994-03-11 1995-09-14 Smithkline Beecham Plc Novel phenyl(-alkyl/alkoxy)-1-aminoalkyl-substituted piperidines and pyrrolidines as calcium channel antagonists
FR2726267B1 (fr) 1994-10-26 1998-01-02 Smithkline Beecham Lab Nouveaux agents anti-arythmiques, compositions pharmaceutiques les contenant, et procede pour les preparer
JP3969741B2 (ja) 1995-11-17 2007-09-05 マーク アンド カンパニー インコーポレイテッド アセチルコリン受容体の修飾因子として役立つ新規置換アリール化合物
TWI240627B (en) 1996-04-26 2005-10-01 Chugai Pharmaceutical Co Ltd Erythropoietin solution preparation
TW544448B (en) * 1997-07-11 2003-08-01 Novartis Ag Pyridine derivatives
CN1154489C (zh) 1997-08-14 2004-06-23 弗·哈夫曼-拉罗切有限公司 抗神经学疾病的杂环乙烯基醚
CN1261098C (zh) 1998-08-28 2006-06-28 西奥斯股份有限公司 p38－α激酶的抑制剂
AU4143300A (en) 1999-04-28 2000-11-17 Takeda Chemical Industries Ltd. Cyclic amide compounds, process for the preparation of the same and uses thereof
DE60041584D1 (de) 1999-07-28 2009-04-02 Aventis Pharma Inc Substituierte oxoazaheterozyclische verbindungen
EP1214303A1 (en) 1999-08-31 2002-06-19 Merck & Co., Inc. Heterocyclic compounds and methods of use thereof
AU779442B2 (en) 2000-01-20 2005-01-27 Eisai Co. Ltd. Novel piperidine compounds and drugs containing the same
JP4282048B2 (ja) * 2000-01-20 2009-06-17 エーザイ・アール・アンド・ディー・マネジメント株式会社 新規ピペリジン化合物およびその医薬
JP2003529594A (ja) 2000-03-31 2003-10-07 ブリストル−マイヤーズ スクイブ ファーマ カンパニー Ａβタンパク質産生の阻害剤としてのサクシノイルアミノ複素環
WO2002046166A1 (en) 2000-12-04 2002-06-13 F. Hoffmann-La Roche Ag Phenylethenyl or phenylethinyl derivatives as glutamate receptor antagonists
DE60214138T2 (de) * 2001-02-21 2007-03-29 Janssen Pharmaceutica N.V. Isoxazolin-derivate als antidepressiva
JP2004536085A (ja) 2001-06-14 2004-12-02 バーテックス　ファーマシューティカルズ　インコーポレイテッド ニューロン損傷を処置するのに有用なアシル化ピペラジン誘導体およびピペリジン誘導体
CN1524315B (zh) 2001-07-06 2013-02-13 日本化药株式会社 染料敏化的光电转换器件
US7751556B2 (en) 2001-07-17 2010-07-06 Sharp Kabushiki Kaisha Apparatus and method of generating falsification detecting data of encrypted data in the course of process
US6995144B2 (en) * 2002-03-14 2006-02-07 Eisai Co., Ltd. Nitrogen containing heterocyclic compounds and medicines containing the same
CN2562229Y (zh) * 2002-07-23 2003-07-23 昆山新力精密五金有限公司 散热器中的散热叶片之装置
AU2003248122A1 (en) * 2002-07-25 2004-02-16 Kotobuki Pharmaceutical Co., Ltd. Sodium channel inhibitor
WO2004037817A1 (ja) 2002-10-25 2004-05-06 Mitsubishi Pharma Corporation Ｎ−オキシド化合物
KR20050114641A (ko) 2003-03-07 2005-12-06 아스텔라스세이야쿠 가부시키가이샤 2,6-이치환된 스티릴을 갖는 질소 함유 헤테로환 유도체
KR20070050961A (ko) * 2004-09-01 2007-05-16 아스텔라스세이야쿠 가부시키가이샤 피페리딘 유도체 또는 이의 제약학적으로 허용되는 염

Also Published As

Publication number Publication date
NO20054607D0 (no) 2005-10-06
CN1756740A (zh) 2006-04-05
AU2004218115A1 (en) 2004-09-16
JPWO2004078715A1 (ja) 2006-06-08
CA2517081A1 (en) 2004-09-16
EP1602645A4 (en) 2008-12-03
MXPA05009290A (es) 2006-05-31
RU2333200C2 (ru) 2008-09-10
KR20050114641A (ko) 2005-12-06
ZA200507486B (en) 2007-03-28
NO20054607L (no) 2005-12-06
EP1602645A1 (en) 2005-12-07
RU2005131014A (ru) 2006-05-10
WO2004078715A1 (ja) 2004-09-16
US8044206B2 (en) 2011-10-25
JP4610480B2 (ja) 2011-01-12
US20070099956A1 (en) 2007-05-03
CN100516040C (zh) 2009-07-22

Similar Documents

Publication Publication Date Title
BRPI0408136A (pt) derivados heterocìclicos contendo nitrogênio tendo estirila 2,6-dissubstituìda
SE0300010D0 (sv) Novel Compounds
CY1107850T1 (el) Παραγωγα θειαδιαζολυλοπιπεραζiνης mε χρησιμοτητα στην αποτροπη ή στην αγωγη εναντι tου αλγους
TW200716628A (en) Novel compounds
BR0214343A (pt) Inibidores de 11 - beta - hidroxi esteróide desidrogenase tipo 1
UA94901C2 (ru) Антибактериальные производные пиперидина
DK1697370T3 (da) Azabicykliske heterocykliske forbindelser som cannabinoidreceptormodulatorer
UA90518C2 (ru) Фармацевтическая композиция в форме таблетки, которая имеет улучшеное всасывание при трансбукальном введение, которая содержит наркотический активный ингредиент и амин
MX2007003546A (es) Derivados de indozolona como inhibidores de 11-beta- hidroxiesteroide-deshidrogenasa.
NO20042161L (no) Inhibitorer av 11-beta-hydroksysteroid dehydrogenase type 1
NZ324887A (en) Piperazine and piperidine compounds with analgesic effect
WO2004032909A3 (en) Stabilized pharmaceutical composition containing basic excipients
SE0401342D0 (sv) Therapeutic compounds
CU23367A3 (es) Formulación de moxifloxacino con sal común
SE0401345D0 (sv) Therapeutic compounds: Pyridine as scaffold
SE0402762D0 (sv) Indazole sulphonamide derivatives
PA8451801A1 (es) Derivados de la 9-oxima eritromicina
SE9900961D0 (sv) Novel compounds
BR0313385A (pt) Derivados de pirimidina-2,4-diona como inibidores de metaloproteinase da matriz
BR0012696A (pt) Composição oftálmica
MY140630A (en) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
SE0300908D0 (sv) Azaindole derivatives, preparations thereof, uses thereof and compositions containing them
GEP20084437B (en) Novel lincomycin derivatives possessing antimicrobial activity
BR0314843A (pt) Novo composto
BR0116060A (pt) Composição farmacêutica de dronedarona para administração parenteral

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2144 DE 07/02/2012.